Source:http://linkedlifedata.com/resource/pubmed/id/16970944
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2006-9-26
|
pubmed:abstractText |
Insulin-like growth factor (IGF-1) plays an important role in prostate cancer development. Recent studies suggest that IGF-1 has mitogenic action through epidermal growth factor receptor (EGFR). However, the mechanism remains largely unknown. Here, we demonstrated in prostate cancer DU145 cells that IGF-1 induced EGFR transactivation, leading to ERK activation. Matrix metalloproteinase-mediated shedding of heparin-binding EGF is involved in this process. Antioxidants and catalase inhibited IGF-1-stimulated EGFR phosphorylation, indicating that H(2)O(2) is required for EGFR activation. However, exogenous H(2)O(2) did not activate EGFR or IGF-1R in DU145 cells. IGF-1 did not induced production of H(2)O(2) in DU145 cells. Our results suggest that transactivation of EGFR by IGF-1 requires basal intracellular H(2)O(2) in DU145 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP...,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
580
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5161-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16970944-Cell Line, Tumor,
pubmed-meshheading:16970944-Cell Proliferation,
pubmed-meshheading:16970944-Enzyme Activation,
pubmed-meshheading:16970944-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:16970944-Humans,
pubmed-meshheading:16970944-Hydrogen Peroxide,
pubmed-meshheading:16970944-Insulin-Like Growth Factor I,
pubmed-meshheading:16970944-Male,
pubmed-meshheading:16970944-Phosphorylation,
pubmed-meshheading:16970944-Prostatic Neoplasms,
pubmed-meshheading:16970944-Protein Processing, Post-Translational,
pubmed-meshheading:16970944-Receptor, Epidermal Growth Factor,
pubmed-meshheading:16970944-Transcriptional Activation
|
pubmed:year |
2006
|
pubmed:articleTitle |
Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide.
|
pubmed:affiliation |
The Institute for Nutritional Sciences, Shanghai Institute for Biological Sciences, Graduate School of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|